Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Granulocyte Colony-Stimulating Factor in Repeated Ivf Failure, a Randomized Trial Publisher Pubmed



Aleyasin A1 ; Abediasl Z2 ; Nazari A3 ; Sheikh M1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Infertility, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Infertility, Bahman Hospital, Tehran, Iran
  3. 3. Omid Infertility Clinic, Tehran, Iran
  4. 4. Maternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Reproduction Published:2016


Abstract

Recent studies have revealed key roles for granulocyte colony-stimulating factor (GCSF) in embryo implantation process and maintenance of pregnancy, and some studies showed promising results by using local intrauterine infusion of GCSF in patients undergoing in vitro fertilization (IVF). This multicenter, randomized, controlled trial included 112 infertile women with repeated IVF failure to evaluate the efficacy of systemic single-dose subcutaneous GCSF administration on IVF success in these women. In this study, the Long Protocol of ovarian stimulation was used for all participants. Sealed, numbered envelopes assigned 56 patients to receive subcutaneous 300 μg GCSF before implantation and 56 in the control group. The implantation (number of gestational sacs on the total number of transferred embryos), chemical pregnancy (positive serum β-HCG), and clinical pregnancy (gestational sac and fetal heart) rates were compared between the two groups. This trial is registered at www.irct.ir (IRCT201503119568N11). The successful implantation (18% vs 7.2%, P = 0.007), chemical pregnancy (44.6% vs 19.6%, P = 0.005), and clinical pregnancy (37.5% vs 14.3%, P = 0.005) rates were significantly higher in the intervention group than in the control group. After adjustment for participants' age, endometrial thickness, good-quality oocyte counts, number of transferred embryos, and anti-Mullerian hormone levels, GCSF treatment remained significantly associated with successful implantation (OR = 2.63, 95% CI = 1.09-6.96), having chemical pregnancy (OR= 2.74, 95% CI = 1.11-7.38) and clinical pregnancy (OR = 2.94, 95% CI = 1.23-8.33). In conclusion, administration of single-dose systemic subcutaneous GCSF before implantation significantly increases the IVF success, implantation, and pregnancy rates in infertile women with repeated IVF failure. © 2016 Society for Reproduction and Fertility.
Experts (# of related papers)
Other Related Docs
9. Novel Immunotherapeutic Approaches for Treatment of Infertility, Biomedicine and Pharmacotherapy (2016)